Recurrent and persistent hematuria with unspecified morphologic changes
ICD-10 N02.9 is a billable code used to indicate a diagnosis of recurrent and persistent hematuria with unspecified morphologic changes.
Recurrent and persistent hematuria refers to the presence of blood in the urine that occurs repeatedly over time, without identifiable morphologic changes in the urinary tract. This condition can be associated with various underlying renal pathologies, including nephritis, nephrotic syndrome, and glomerulonephritis. Nephritis, characterized by inflammation of the kidneys, can lead to hematuria due to damage to the glomeruli, which are the filtering units of the kidneys. Nephrotic syndrome, marked by significant proteinuria, can also present with hematuria, although the primary symptom is often edema and protein loss. Glomerulonephritis, an inflammation of the glomeruli, is a common cause of hematuria and may require renal biopsy for definitive diagnosis. Management in nephrology typically involves addressing the underlying cause, which may include corticosteroids, immunosuppressants, or other targeted therapies. Regular monitoring of renal function and urine analysis is essential to assess the progression of the disease and the effectiveness of treatment.
Detailed history of hematuria episodes, renal function tests, and biopsy results.
Patients presenting with recurrent hematuria, proteinuria, and renal impairment.
Ensure all relevant laboratory results and imaging studies are documented to support the diagnosis.
Comprehensive evaluation of urinary tract, including imaging and cystoscopy findings.
Patients with hematuria requiring urological assessment for potential malignancies.
Document any interventions or procedures performed to evaluate hematuria.
When renal biopsy is performed to evaluate the cause of hematuria.
Pathology report and clinical notes indicating the need for biopsy.
Nephrology specialists should ensure that the rationale for biopsy is clearly documented.
Specifying morphologic changes helps in identifying the underlying cause of hematuria, which can influence treatment decisions and prognosis. Without this specification, the diagnosis remains broad and may complicate management.
